Using Kaligo+ to help children aged 6 to 11 with writing difficulties learn to write
Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders: a Multiple Baseline Online SCED Study
This study is testing a new tool called Kaligo+ to see if it can help children aged 6 to 11 who have trouble writing improve their handwriting skills.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 6 Years to 11 Years |
| Sex | All |
| Sponsor | Fondation Ildys Academic / other |
| Locations | 1 site (Brest) |
| Trial ID | NCT06858566 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Kaligo+ solution, an innovative learning tool designed to assist children aged 6 to 11 who struggle with writing disorders. By utilizing engaging technology such as tablets and virtual reality, the study aims to enhance the learning experience and improve handwriting skills in children facing significant challenges. The pilot study will involve 15 children, assessing their progress through tailored interventions that incorporate advanced feedback mechanisms. The goal is to determine whether this modern approach can lead to meaningful improvements in writing abilities.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 11 who exhibit writing difficulties and may or may not be receiving existing care for these issues.
Not a fit: Children with moderate, severe, or profound intellectual disabilities, or those who cannot use tablets or virtual reality due to contraindications, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance writing skills in children with handwriting disorders, leading to better academic performance and increased independence.
How similar studies have performed: Initial studies using technology-based interventions for writing difficulties have shown promise, suggesting that this approach may be effective, though this specific application remains novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with writing difficulties (who may or may not be receiving care in this area) * Age: 6 - 11 years * Score \> 1 standard deviation on the BHK deterioration score Exclusion Criteria: * Contraindication to the use of the tablet or virtual reality * Moderate, severe or profound intellectual disability (Total Intelligence Quotient below 55 on an intellectual efficiency scale such as WISC-V or K-ABC-II).
Where this trial is running
Brest
- Fondation ILDYS — Brest, France (Recruiting)
Study contacts
- Principal investigator: Christelle PONS BECMEUR, MP/PhD — Fondation Ildys
- Study coordinator: Manon LE GOFF
- Email: manon.legoff@ildys.org
- Phone: 0298028308
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.